Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0842
D

Failure to Accurately Document Discontinuation of Antipsychotic Medication

Phoenix, Arizona Survey Completed on 01-29-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to accurately document the discontinuation of an antipsychotic medication and the rationale for that change in a resident’s clinical record. The resident was admitted from the hospital with an order for olanzapine 2.5 mg daily and had moderate cognitive impairment with no documented behavioral symptoms during the MDS assessment period. Facility physician orders showed olanzapine was started with an indefinite end date, and the MAR reflected administration for several days, with the medication discontinued on November 11, 2025, at 11:41 a.m. A behavioral monitoring order related to olanzapine, initiated the day before, remained active through the resident’s discharge, and no behavioral symptoms were documented during that time. On the same day olanzapine was discontinued, a psychiatry progress note by a PA documented that this was the initial psychiatric visit and stated that no medication changes were recommended, without noting the discontinuation of olanzapine and directing staff to refer to the MAR for non-pharmacologic interventions. A telephone discontinue order for olanzapine was entered by an LPN as a telephone order from the same PA, and the MAR confirmed no further doses were given after that date. Subsequent nurse practitioner notes on two later dates documented that the resident would continue olanzapine and benztropine for psychosis, despite the medication having been discontinued and not provided, and the resident was ultimately discharged without a prescription for olanzapine. Interviews with nursing and pharmacy staff, as well as the PA, confirmed that the discontinuation was not documented in the progress note and that behavioral monitoring and alert charting were not updated, contrary to facility policies requiring accurate documentation of physician-ordered services and nursing documentation of treatment and order changes.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙